CCXX

NEW YORK, Oct. 13, 2020 /PRNewswire/ -- The year 2020 has already seen 127 SPAC IPOs, which have collectively raised over $48.5 billion in proceeds — more than the past ten years combined. A special purpose acquisition company (SPAC) is essentially a blank-check company formed to raise capital through an IPO with the sole intent of buying or merging with another operating company. SPACs have evolved to become an expedited and cost-effective way of doing an M&A deal and have been utilized by multiple Wall Street heavyweights. Going public via a SPAC enables a company to get a deal done in weeks instead of months, and the approach is proving to be an especially attractive vehicle for biotec

NEW YORK, Oct. 8, 2020 /PRNewswire/ -- Churchill Capital Corp III ("Churchill III") (NYSE: CCXX), a public investment vehicle, and the parent of MultiPlan, Inc. ("MultiPlan"), a leading value-added provider of data analytics and technology-enabled end-to-end cost management solutions to the U.S. healthcare industry, today announced the completion of their business combination. The business combination will enable MultiPlan to embark on its next phase of growth while continuing its mission to make healthcare in the U.S. affordable, accessible, efficient and fair. It is anticipated that the combined company's New York Stock Exchange ticker symbol will be changed to "MPLN" beginning on Octob

NEW YORK, Oct. 7, 2020 /PRNewswire/ -- Churchill Capital Corp III ("Churchill III") (NYSE: CCXX), a public investment vehicle, announced that in a special meeting held today, its stockholders voted to approve its combination with Polaris Parent Corp., the parent of MultiPlan, Inc. ("MultiPlan"), a leading value-added provider of data analytics and technology-enabled end-to-end cost management solutions to the U.S. healthcare industry, and related matters. Approximately 93% of the votes cast at the meeting, representing approximately 76% of Churchill III's outstanding shares, voted to approve the business combination.  The consummation of the business combination is currently expected to o

NEW YORK, Oct. 5, 2020 /PRNewswire/ -- Churchill Capital Corp III ("Churchill III") (NYSE: CCXX), a public investment vehicle, today made the following statement: M. Klein & Company LLC ("MKC"), an affiliate of Churchill III's sponsor, or one or more affiliates of MKC intends to acquire an additional $50 million of Churchill III's outstanding shares, either through purchases on the open market or through privately negotiated transactions as appropriate. MKC believes Churchill III's shares currently are undervalued and do not reflect the future opportunity of the company. The timing and actual numbers of shares purchased will depend on a variety of factors, including price and other market

NEW YORK, Oct. 5, 2020 /PRNewswire/ -- Churchill Capital Corp III ("Churchill III") (NYSE: CCXX), a public investment vehicle, and MultiPlan, Inc. ("MultiPlan"), a leading value-added provider of data analytics and technology-enabled end-to-end cost management solutions to the U.S. healthcare industry, announced today that, based on MultiPlan's recent strong financial performance and favorable market conditions, MultiPlan has launched a process to refinance its 7.125% Senior Notes due 2024 and indebtedness under its existing senior secured credit facilities with the goal of meaningfully lowering annual interest expense, extending maturities and increasing access to liquidity. MultiPlan is

NEW YORK, Oct. 2, 2020 /PRNewswire/ -- Churchill Capital Corp III ("Churchill III") (NYSE: CCXX), a public investment vehicle, today confirmed the special meeting of stockholders to approve the pending combination with Polaris Parent Corp., the parent of MultiPlan, Inc ("MultiPlan"), will be held at 10:00 a.m. Eastern Time on October 7, 2020 via live webcast.  The proxy statement is available in the Investor Resources section of Churchill III's website as well as on www.sec.gov. The consummation of the business combination is currently expected to occur on October 8, 2020, the day immediately following the special meeting of stockholders, subject to final stockholder approval and satisfac